N/A N=33 HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis
End Stage Renal Disease (ESRD)
Primary: Mortality — 18.8; 29.4 percentage of participants who died — p=0.48
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=158 Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores
Oral Herpes Simplex
Primary: Number of Participants for Whom a Recurrent Oral Herpes Episode Initiated With Prodromal Symptoms Were Aborted Before Progressing to a Lesion as Assessed by a Trained…
Phase 2 N=196 A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
ER Positive, Her2 Negative Breast Cancer Patients · Triple Negative Breast Cancer Patients
Primary: Number of Participants With Pathologic Complete Response (pCR) (Rate of pCR) — 59; 29; 32; 14 participants
Phase 3 N=25 Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches
Refractory Migraine
Primary: Mean Number of Days of Decrease in Pain Level Using VAS — 1.20; 8.67 days — p=0.0347
N/A N=81 Intranasal Dexmedetomidine Premedication
Benign Neoplasm of Vocal Fold - Glottis
Primary: Extubation Time After Intranasal Dexmedetomidine Premedication — 18.58; 17.16; 16.21; 14.74 min
Phase 4 N=81 Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris
Acne
Primary: Total Lesion Count — 76.7; 53.9; 50.0; 43.7 lesions
N/A N=4 Health Coaching for Glaucoma Patients
Glaucoma
Primary: Glaucoma Medication Adherence — 72 percentage of adherence time
Phase 3 N=417 BOTOX® in the Treatment of Crow's Feet Lines in China
Lateral Canthal Lines · Crow's Feet Lines
Primary: Percentage of Subjects Achieving None or Mild on the Investigator's Assessment of the Severity of Crow's Feet Lines (CFL) at Maximum Smile Using the Facial Wrinkle…
Phase 2 N=217 Treatment of Apogeotropic Horizontal Canal Benign Paroxysmal Positional Vertigo
Benign Paroxysmal Positional Vertigo
Primary: Conversion in Direction of Nystagmus From Apogeotropic to Geotropic or Disappearance of Nystagmus — 51; 46; 38 participants — p=0.02839
N/A N=140 Nitrous Oxide for Pain Management of First Trimester Surgical Abortion
Abortion in First Trimester
Primary: Visual Analog Pain Score for Mean Maximum Procedural Pain — 54.37; 60.48 units on a scale
N/A N=172 Special Investigation in Patients With Rheumatoid Arthritis (HOPEFUL III Study), a Follow-up Survey of Study P12-069
Rheumatoid Arthritis
Primary: Percentage of Participants With Disease Activity Score 28 - C-Reactive Protein (DAS28-CRP) Score < 3.2 After Discontinuation of Adalimumab Treatment — 100.0; 77.9; 71.4…
Phase 2 N=19 Study of Obese Subjects Previously Implanted With the EndoBarrier Gastrointestinal Liner
Obesity
Primary: Assessment of the % Excess Weight Loss at Week 52 or Last Assessment — 26.9 %EWL
Phase 2 N=102 Near Infrared Spectroscopy (NIRS) as Transfusion Indicator in Neurocritical Patients
Traumatic Brain Injury · Subarachnoid Hemorrhage · Intracerebral Hemorrhage
Primary: Number of Units of Packed Red Blood Cell Transfused — 0.9; 1.5 units — p=0.03
N/A N=74 Daily Disposable Comparison Study
Myopia
Primary: Lens Preference - Filcon II 3 and Etafilcon A or Filcon II 3 and Nelfilcon A — 1; 3; 14; 8 participants
N/A N=32 Impaired Regulation of Energy Balance in Elderly People (Balance Study)
Anorexia of Ageing
Primary: Energy Intake Compensation — 1; 1 MJ/day